Chronic administration of sildenafil in diabetic type II (T2DM) patients reduces levels of endothelin, C-reactive protein, interleukin-6, intercellular adhesion molecules (ICAM), and vascular adhesion molecules (VCAM), as well as reducing nitrate/nitrite levels [157]. This evidence concerns the gene CRP and type 2 diabetes mellitus.